Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Adjunctive Therapy in High-grade Glioma
NCT05929495Phase 2Recruiting
- Sponsor
- University of Milano-Bicocca
- Start
- Feb 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in glioblastoma (GBM), sponsored by University of Milano-Bicocca. Started Feb 2024; status: recruiting.
02
Drugs
metformin
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT05929495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05929495.